FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medical products and concerns a combination for prostate cancer treatment containing effective amounts of N-(3-methoxy-5-methylpyrazine-2-yl)-2-(4-[1,3,4-oxadiazol-2-yl]phenyl)pyridine-3-sulphonamide or its pharmaceutically acceptable salt and pamidronate. There is also disclosed a method of prostate cancer treatment and application of the combination for preparing a medicinal agent used in prostate cancer treatment.
EFFECT: combination under the invention exhibits synergetic effect with respect to inhibiting metastases to bone and soft tissues in prostate cancer treatment.
4 cl
| Title | Year | Author | Number |
|---|---|---|---|
| COMBINATION CONTAINING N-METHOXY-3-METHYLPYRAZINE-2-YL)-2-(4-[1,3,4-OXADIAZOL-2-YL]PHENYL)PYRIDINE-3-SULFONAMIDE AND ANTIMITOTIC SUBSTANCE FOR MALIGNANT GROWTH | 2005 |
|
RU2428188C2 |
| THERAPEUTIC APPLICATION | 2003 |
|
RU2340343C2 |
| COMBINATION OF PHOSPHATIDYL INOSITOL-3-KINASE (PI3K) INHIBITOR AND mTOR INHIBITOR | 2009 |
|
RU2538683C2 |
| PHARMACEUTICAL COMPOSITION FOR USING IN THERAPY OF MALIGNANT NEOPLASM COMPRISING COMBINATION OF BISPHOSPHONATE, COX-2 INHIBITOR AND TAXOL | 2002 |
|
RU2317819C2 |
| 3'-DEAMINO-3'-(2"-PYRROLINE-1"-YL)-5-IMINO-13-DEOXYANTRACYCLINS AND PRODUCTION METHODS | 2018 |
|
RU2803586C2 |
| COMBINED CHEMOTHERAPY | 2001 |
|
RU2284818C2 |
| FORMULATION OF 4-AMINO-2-(2,6-DIOXOPIPERIDIN-3-YL)ISOINDOLINE-1,3-DIONE | 2010 |
|
RU2479307C1 |
| COMBINED CHEMOTHERAPY | 2010 |
|
RU2587013C2 |
| COMBINED CHEMOTHERAPY | 2006 |
|
RU2429838C2 |
| COMBINATION TREATMENT | 2014 |
|
RU2666999C2 |
